Home
Profile
Manufacturing
Quality Control
Products
  Contact Us Careers Sitemap          
   
 
:: Research & Development
:: International Collaboration
:: Business Opportunities
:: Latest Events
:: Divisions At a Glance


  press_release_btn_otherspg :: Press Releases vline_separator

  :: In Licensing   inlicensing_btn__otherspg vline_separator

  outlicensing_btn_otherspg :: Out Licensing vline_separator

 
  Amphotericin-B for Injection USP 50 mg
  Indications :
 

Fungal endocarditis

Meningitis

Peritonitis

Severe respiratory tract infections

Fungal infections such as Aspergillosis, Candidiasis etc

Blastomycosis

Histoplasmosis

Cryptococosis

Visceral Leishmaniasis

   
  Dosage :
  Initial Dose : Therapy is usually initiated with a daily dose of 0.25mg/kg of body weight given over 2 to 6 hours.

Systemic candidiasis : Usual doses ranging from 0.4 to 0.6 mg/kg/day for 4 or more weeks. Doses up to 1 mg/kg/day may need to be employed depending upon the severity of the infection.

Aspergillosis : Doses of 0.5 to 1 mg/kg/day or more & cumulative doses of 2 to 4 g in adults may be required for serious infections.

Blastomycosis : In seriously ill patients with blastomycosis, doses ranging from 0.3 to 1 mg/kg/day to a total cumulative dose of 1.5 to 2.5 g.

Cryptococcosis : Doses of 0.3 mg/kg/day for periods approximating (Cryptococcosis in non 4 to 6 weeks or until weekly cultures are negative immunosuppressed for one month patients).

Histoplasmosis : Doses approx. 0.5 to 1 mg/kg/day to a total cumulative (Chronic pulmonary dose of 2 to 2.5 g. or disseminated histoplasmosis).

Usual Pediatric Dose : 100 -250 mcg /kg body weight.

Renally Impaired Patients : Depending on the patient's cardio-renal status doses may gradually be increased by 5 to 10 mg per day to final daily dosage of 0.5 to 0.7 mg/kg.
   
  Packing : 10 Vials of 50 mg
 



  Home | Careers | Site map | Contact Us



 
  All contents copyright © United Biotech (P) Limited, All rights reserved.